Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the exchanges that its Board of Directors will meet on Wednesday, August 13, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The trading window for designated persons and their immediate relatives remains closed until 48 hours after the results are declared, in line with insider trading regulations. This is a routine regulatory intimation under SEBI LODR Regulation 29 and does not contain any financial figures.
No direct impact on shareholders at this stage. Investors should watch for the actual Q1 FY26 results on or after August 13, 2025, to assess the company's quarterly performance and any management commentary.